Table 3. Comparing Average Change From Baseline at 6 Months and 12 Months for the ENBPG Group vs the UC Group.

Parameter and Measurement Period	EBNPG Group		UC Group		P Significance of Difference Between EBNPG and UC
	n	Mean ± SD Change From Baseline	n	Mean ± SD Change From Baseline
HbA1C, mg/dL
6 mo	37	−1.69 ± 1.89b	81	−1.30 ± 2.44b	.39
12 mo	35	−1.03 ± 1.94c	77	−1.02 ± 2.49b	.99
Body mass index
6 mo	23	−0.78 ± 1.45d	45	−0.27 ± 1.58	.20
12 mo	17	−0.95 ± 1.87d	42	−0.52 ± 1.95	.43
Total cholesterol, mg/dL
6 mo	37	−11.0 ± 40.9	81	−6.0 ± 38.6	.51
12 mo	35	−14.9 ± 30.0c	77	−6.7 ± 36.3	.25
LDL cholesterol, mg/dL
6 mo	37	−0.8 ± 30	81	−4.5 ± 31	.54
12 mo	35	−11 ± 20c	77	−5.6 ± 30	.25
HDL cholesterol, mg/dL
6 mo	37	+2.0 ± 4.3c	81	+0.7 ± 6.5	.18
12 mo	35	+1.6 ± 4.9c	77	+0.2 ± 9.6	.30
Triglyceride, mg/dLa
6 mo	37	−87 ± 348c	81	−3 ± 89	.01
12 mo	35	−74 ± 224c	77	−4 ± 85	.01

Abbreviations: EBNPG, evidence-based nutrition practice guideline; HbA_1C, hemoglobin A_1C; HDL, high-density lipoprotein; LDL, low-density lipoprotein; UC, usual care.

^aSignificance established after log transformation with 2-sample t test.

^bP ≤ .001 significance of change from baseline within group using paired-samples t test.

^cP ≤ .01 significance of change from baseline within group using paired-samples t test.

^dP ≤ .05 significance of change from baseline within group using paired-samples t test.